Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
granules india
Jump to
356 Results Found
  • Granules India share price up 3% on USFDA approval Jan 13, 2021 12:48 PM IST

    Granules India share price up 3% on USFDA approval

    The share touched its 52-week high Rs 438.00 and 52-week low Rs 114.50 on 01 December, 2020 and 23 March, 2020, respectively.

  • Buy Granules India: target of Rs 475: Sharekhan Jan 07, 2021 03:29 PM IST

    Buy Granules India: target of Rs 475: Sharekhan

    Sharekhan is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 475 in its research report dated January 06, 2020.

  • Granules India shares gain on US FDA approval for generic of Cuprimine, Penicillamine capsules Dec 04, 2020 09:40 AM IST

    Granules India shares gain on US FDA approval for generic of Cuprimine, Penicillamine capsules

    Granules India announced that the US FDA has approved the ANDA filed by Granules Pharmaceuticals, Inc (GPI)., for Penicillamine Capsules USP, 250 mg, the company said in an exchange filing.

  • Granules India board gives nod to set up subsidiary in Hyderabad Nov 09, 2020 11:29 AM IST

    Granules India board gives nod to set up subsidiary in Hyderabad

    The company, however, did not share more details.

  • Buy Granules India; target of Rs 460: ICICI Direct Nov 03, 2020 09:44 PM IST

    Buy Granules India; target of Rs 460: ICICI Direct

    ICICI Direct is bullish on Granules India recommended buy rating on the stock with a target price of Rs 460 in its research report dated October 21, 2020.

  • Buy Granules India; target of Rs 459: KRChoksey Oct 22, 2020 04:01 PM IST

    Buy Granules India; target of Rs 459: KRChoksey

    KRChoksey is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 459 in its research report dated October 22, 2020.

  • Buy Granules India; target of Rs 455: Anand Rathi Oct 22, 2020 02:22 PM IST

    Buy Granules India; target of Rs 455: Anand Rathi

    Anand Rathi is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 455 in its research report dated October 22, 2020.

  • Buy Granules India; target of Rs 500: Motilal Oswal Oct 21, 2020 02:40 PM IST

    Buy Granules India; target of Rs 500: Motilal Oswal

    Motilal Oswal is bullish on Granules India recommended buy rating on the stock with a target price of Rs 500 in its research report dated October 20, 2020.

  • Granules India Standalone September 2020 Net Sales at Rs 834.50 crore, up 30.64% Y-o-Y Oct 21, 2020 09:00 AM IST

    Granules India Standalone September 2020 Net Sales at Rs 834.50 crore, up 30.64% Y-o-Y

  • Granules India Consolidated September 2020 Net Sales at Rs 858.12 crore, up 22.67% Y-o-Y Oct 21, 2020 09:00 AM IST

    Granules India Consolidated September 2020 Net Sales at Rs 858.12 crore, up 22.67% Y-o-Y

  • Granules India shares hit 52-week high as global equity firms eye controlling stake Sep 25, 2020 10:09 AM IST

    Granules India shares hit 52-week high as global equity firms eye controlling stake

    KKR, Bain Capital and Blackstone have expressed interest in acquiring a controlling stake in the company.

  • KKR, Bain Capital and Blackstone in race for majority stake in Granules India Sep 24, 2020 10:07 PM IST

    KKR, Bain Capital and Blackstone in race for majority stake in Granules India

    Investment bank Kotak Mahindra Capital has been engaged by the promoters of Granules India to scout for buyers.

  • Buy Granules India; target of Rs 410: Motilal Oswal Sep 14, 2020 12:35 PM IST

    Buy Granules India; target of Rs 410: Motilal Oswal

    Motilal Oswal is bullish on Granules India recommended buy rating on the stock with a target price of Rs 410 in its research report dated September 12, 2020.

  • Promoters of Hyderabad-based Granules India revive exit plans Sep 10, 2020 02:59 PM IST

    Promoters of Hyderabad-based Granules India revive exit plans

    Recent deals like Advent-Ra Chem Pharma, Carlyle – Sequent Scientific and Carlyle –Piramal Enterprises are examples of rising interest from private equity funds in the domestic active pharmaceutical ingredients segment.

  • Buy Granules India; target of Rs 330: Anand Rathi Jul 21, 2020 06:05 PM IST

    Buy Granules India; target of Rs 330: Anand Rathi

    Anand Rathi recommended hold rating on Granules India with a target price of Rs 330 in its research report dated July 20, 2020.

  • Buy Granules India; target of Rs 327: Geojit Jul 21, 2020 01:55 PM IST

    Buy Granules India; target of Rs 327: Geojit

    Geojit recommended is bullish on Granules India recommended buy rating on the stock with a target price of Rs 327 in its research report dated July 20, 2020.

  • Buy Granules India; target of Rs 340: Emkay Global Financial Jul 21, 2020 01:43 PM IST

    Buy Granules India; target of Rs 340: Emkay Global Financial

    Emkay Global Financial is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 340 in its research report dated July 17, 2020.

  • Buy Granules India ; target of Rs 315: Motilal Oswal Jul 20, 2020 12:14 PM IST

    Buy Granules India ; target of Rs 315: Motilal Oswal

    Motilal Oswal is bullish on Granules India recommended buy rating on the stock with a target price of Rs 765 in its research report dated July 18, 2020.

  • Granules India Standalone June 2020 Net Sales at Rs 742.92 crore, up 30.83% Y-o-Y Jul 20, 2020 09:25 AM IST

    Granules India Standalone June 2020 Net Sales at Rs 742.92 crore, up 30.83% Y-o-Y

  • Granules India Q1 net profit rises 34% to Rs 111.4 crore Jul 17, 2020 04:00 PM IST

    Granules India Q1 net profit rises 34% to Rs 111.4 crore

    The company had posted a net profit of Rs 83.24 crore for the corresponding period of the previous financial year, Granules India said in a filing to the BSE.

  • Granules India shares hit new high after Q1 profit jumps 34% Jul 17, 2020 12:48 PM IST

    Granules India shares hit new high after Q1 profit jumps 34%

    The company's consolidated net profit rose 34 percent to Rs 111.4 crore against Rs 83.2 crore YoY. Its consolidated revenue went up 23.6 percent at Rs 735.6 crore against Rs 595.3 crore YoY.

  • Buy Granules India; target of Rs 227: Anand Rathi Jun 05, 2020 09:34 AM IST

    Buy Granules India; target of Rs 227: Anand Rathi

    Anand Rathi is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 227 in its research report dated June 03, 2020.

  • Granules India Standalone March 2020 Net Sales at Rs 486.87 crore, down 13.21% Y-o-Y Jun 03, 2020 09:50 AM IST

    Granules India Standalone March 2020 Net Sales at Rs 486.87 crore, down 13.21% Y-o-Y

  • Granules India Consolidated March 2020 Net Sales at Rs 599.88 crore, down 2.19% Y-o-Y Jun 03, 2020 09:07 AM IST

    Granules India Consolidated March 2020 Net Sales at Rs 599.88 crore, down 2.19% Y-o-Y

  • JB Chemicals, Granules share price up 2-4% on USFDA approval Apr 27, 2020 12:30 PM IST

    JB Chemicals, Granules share price up 2-4% on USFDA approval

    Granules has a total of 27 ANDA approvals from US FDA (25 Final approvals and 2 tentative approvals).

Sections